A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · PARALLEL · PREVENTION · DOUBLE
- Evidence population
- Human clinical study registration
- Participants
- 40
- Population
- ALL · 60 Years
- Duration
- 2026-03-02 to 2026-10-30
- Intervention
- Aerobic exercise program
- Comparator
- Control Group
- Outcomes measured
- Sodium — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12); After 4 week detraini…; Potassium — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12); After 4 week detra…; Chloride — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12); After 4 week detrai…; Calcium — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12); After 4 week detrain…; Phosphorus — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12); After 4 week detr…; Magnesium — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12); After 4 week detra…; Aspartate aminotransferase (AST) — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T…; Alanine aminotransferase (ALT) — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12…; Gamma-glutamyl transferase (GGT) — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T…; Total bilirubin — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12); After 4 week…; Direct bilirubin — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12); After 4 wee…; Alkaline phosphatase — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12); After 4…; Lactate dehydrogenase (LDH) — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12);…; Total cholesterol — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12); After 4 we…; HDL cholesterol — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12); After 4 week…; LDL cholesterol — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12); After 4 week…; Triglycerides — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12); After 4 week d…; Amylase — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12); After 4 week detrain…; Urea — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12); After 4 week detraining…; Creatinine — Baseline (T0); After 6 weeks of intervention (T6); After 12 weeks of intervention (T12); After 4 week detr…
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Exercise · 100%Title contains controlled term: exercise. Abstract contains controlled term: exercise. Source terminology contains: exercise. Title supplies longevity context: senescence, older adult. Study type is explicitly identified as INTERVENTIONAL.
- Immune ageing · 100%Title contains controlled term: immunosenescence. Abstract contains controlled term: immunosenescence. Source terminology contains: immunosenescence. Title supplies longevity context: senescence, older adult. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.
